While reporting financial results for the second quarter, Meridian Bioscience, Inc. (VIVO) on Tuesday updated its earnings guidance for the full-year 2019, based on the pending acquisition of the business of GenePOC Inc.
from RTT - Earnings http://bit.ly/2WdNjU5
via IFTTT
No comments:
Post a Comment